The CDKL4 Polyclonal Antibody (PAC023752) is a vital tool for researchers studying CDKL4, a protein kinase implicated in cell cycle regulation and neuronal development. This antibody, produced in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blotting applications. By binding specifically to the CDKL4 protein, this antibody enables detection and analysis in various cell types, making it an essential tool for studies in neuroscience and cancer research.CDKL4 is a key player in maintaining proper cell division and differentiation, making it a crucial target for research into diseases such as cancer and neurodevelopmental disorders.
By unraveling the functions of CDKL4, researchers can gain insight into the mechanisms underlying these conditions and potentially identify new therapeutic avenues. The CDKL4 Polyclonal Antibody offers a reliable means of studying this important protein, ultimately advancing our understanding of its roles in health and disease.
